Cookson Peirce & CO Inc Corcept Therapeutics Inc Transaction History
Cookson Peirce & CO Inc
- $2.17 Billion
- Q2 2025
A detailed history of Cookson Peirce & CO Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Cookson Peirce & CO Inc holds 217,422 shares of CORT stock, worth $15.3 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
217,422
Previous 235,819
7.8%
Holding current value
$15.3 Million
Previous $26.9 Million
40.75%
% of portfolio
0.74%
Previous 1.45%
Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
468Shares Held
84.5MCall Options Held
1.42MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.17 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$703 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$544 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$433 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$273 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.55B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...